| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016530A1 New e.coli mutant with suppressed organic acid production |
| 05/09/1997 | WO1997016460A1 Casein fragments having growth promoting activity |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016458A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016207A1 Peptide expression and delivery system |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016205A1 Antitumor agent |
| 05/09/1997 | WO1997016189A1 Combination therapy for the treatment of diabetes and obesity |
| 05/09/1997 | WO1997011179A3 VARIANTS OF HUMAN RECOMBINANT INTERFERON-η (RHU-IFN-η) HAVING INCREASED HEAT-STABILITY |
| 05/09/1997 | WO1997011173A3 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 05/09/1997 | WO1997004089A3 Porphyrin-accumulating type herbicide resistance gene |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236274A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | CA2235670A1 Formation and use of prion protein (prp) complexes |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | CA2208871A1 New e.coli mutant with suppressed organic acid production |
| 05/07/1997 | EP0771877A1 Gene coding for modified bone morphogenic protein receptor |
| 05/07/1997 | EP0771875A1 Porcine CNP gene and precursor protein |
| 05/07/1997 | EP0771874A2 Transgenic protein production |
| 05/07/1997 | EP0771873A2 Neuronal cell-specific receptor protein |
| 05/07/1997 | EP0771871A2 Expression of human serum albumin in methylotrophic yeasts |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771361A2 Diagnostic method and probe |
| 05/07/1997 | EP0771359A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771351A1 Surface protein of staphylococcus aureus |
| 05/07/1997 | EP0771350A1 Growth control for cells encapsulated within bioartificial organs |
| 05/07/1997 | EP0771348A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771326A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 05/07/1997 | EP0771324A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 05/07/1997 | EP0771323A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 05/07/1997 | EP0771322A1 Abundant extracellular products and methods for their production and use |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771213A1 Haemophilus adherence and penetration proteins |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771211A1 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0684999A4 Sequence-directed dna-binding molecules compositions and methods. |
| 05/07/1997 | EP0670907B1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 05/07/1997 | EP0661993B1 Protection against liver damage by hgf |
| 05/07/1997 | EP0656747A4 Composition and method for altering dna sequences by homologous recombination. |
| 05/07/1997 | EP0652957B1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/07/1997 | EP0651764B1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor |
| 05/07/1997 | EP0621870B1 A human kunitz-type protease inhibitor variant |
| 05/07/1997 | EP0612217B1 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | EP0464155B1 Endothelial cell growth factor, isolation and expression |
| 05/07/1997 | EP0458918B1 Method for obtaining a recombinant protein and its utilization in the assay for the african swine pest virus (aspv) |
| 05/07/1997 | EP0357645B1 Improved process for recovering microbially produced interleukin-2 |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/07/1997 | CN1149057A Growth factor of young animal thymus and its extraction and separation method |
| 05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
| 05/06/1997 | USRE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/06/1997 | US5627268 Hemoglobin comprising globin fusion proteins |
| 05/06/1997 | US5627267 Cytokine designated elk ligand |
| 05/06/1997 | US5627266 Neutralizing toxic effect or bioactivity of endotoxin which is isolated from horseshoe crab; immobilized on a solid phase support of chromatographic resin membrane |
| 05/06/1997 | US5627265 Receptor for cell-binding domain of thrombospondins |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |
| 05/06/1997 | US5627263 Wound healing and antitumor agents |
| 05/06/1997 | US5627262 Method and composition for the treatment of septic shock |
| 05/06/1997 | US5627158 Antisense oligonucleotides of human regulatory subunit RI-.sub.α of camp dependent protein kinases for the treatment of cancer |
| 05/06/1997 | US5627156 Polypeptide agonists for human interleukin-8 |
| 05/06/1997 | US5627155 Controlling diseases with proteins such as allergies, psoriasis, tissue rejection and autoimmune diseases |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5627153 Anti-fungal methods and materials |
| 05/06/1997 | US5627073 Hybridomas producing antibodies to cardiac hypertrophy factor |
| 05/06/1997 | US5627067 Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes |
| 05/06/1997 | US5627059 Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same |
| 05/06/1997 | US5627051 Dna sequences for protein having antifreeze properties |
| 05/06/1997 | US5627049 Isolated dna sequence from kluyveromyces |
| 05/06/1997 | US5627047 Astrocyte-specific transcription of human genes |
| 05/06/1997 | US5627046 Yeast promoter and its use |
| 05/06/1997 | US5627043 Production of proteins with dibasic amino acids and cleavage |
| 05/06/1997 | US5627036 Use of an anticoagulant as a diagnostic agent |
| 05/06/1997 | US5627023 Enzyme inhibitors for treatment of aids, cell culture and genetic engineerng |
| 05/06/1997 | US5626851 Rotavirus reassortant vaccine |
| 05/06/1997 | US5626850 Non-shedding live herpesvirus vaccine |
| 05/06/1997 | US5626846 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 05/02/1997 | EP0770874A2 Receptor membranes and ionophore gating |
| 05/02/1997 | EP0770681A2 T cell epitopes of the major allergens from ambrosia artemisiifolia |